760214-55-9Relevant articles and documents
GLYT2 MODULATORS
-
Page/Page column 78, (2010/02/11)
α-, β-, and γ-amino acid derivatives of formula I are disclosed as selective GlyT2 inhibitors for the treatment of central nervous system (CNS) conditions such as muscle spasticity, tinnitus, epilepsy and neuropathic pain. Formula I
Novel glycine transporter type-2 reuptake inhibitors. Part 1: α-amino acid derivatives
Wolin, Ronald L.,Venkatesan, Hariharan,Tang, Liu,Santillán Jr., Alejandro,Barclay, Tristin,Wilson, Sandy,Lee, Doo Hyun,Lovenberg, Timothy W.
, p. 4477 - 4492 (2007/10/03)
A variety of α-amino acid derivatives were prepared as glycine transport inhibitors and their ability to block the uptake of [ 14C]-glycine in COS7 cells transfected with human glycine transporter-2 (hGlyT-2) was evaluated. An array of substituents at the chiral center was studied and overall, L-phenylalanine was identified as the preferred amino acid residue. Compounds prepared from L-amino acids were more potent GlyT-2 inhibitors than analogs derived from the corresponding D-amino acids. Introducing an achiral amino acid such as glycine, or incorporating geminal substitution in the α-position, led to a significant reduction in GlyT-2 inhibitory properties.
Novel glycine transporter type-2 reuptake inhibitors. Part 2: β- and γ-amino acid derivatives
Wolin, Ronald L.,Santillán Jr., Alejandro,Barclay, Tristin,Tang, Liu,Venkatesan, Hariharan,Wilson, Sandy,Lee, Doo Hyun,Lovenberg, Timothy W.
, p. 4493 - 4509 (2007/10/03)
Several β- and γ-amino acid derivatives were prepared as glycine transport inhibitors and their ability to block the uptake of [ 14C]-glycine in COS7 cells transfected with human glycine transporter-2 (hGlyT-2) were evaluated. A range of lipoph
